vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and INDEPENDENT BANK CORP (INDB). Click either name above to swap in a different company.
INDEPENDENT BANK CORP is the larger business by last-quarter revenue ($212.5M vs $185.2M, roughly 1.1× AMICUS THERAPEUTICS, INC.). INDEPENDENT BANK CORP runs the higher net margin — 35.5% vs 0.9%, a 34.5% gap on every dollar of revenue. On growth, INDEPENDENT BANK CORP posted the faster year-over-year revenue change (46.9% vs 23.7%). INDEPENDENT BANK CORP produced more free cash flow last quarter ($75.5M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 24.3%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.
FOLD vs INDB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $212.5M |
| Net Profit | $1.7M | $75.3M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | — |
| Net Margin | 0.9% | 35.5% |
| Revenue YoY | 23.7% | 46.9% |
| Net Profit YoY | -88.5% | 50.6% |
| EPS (diluted) | $0.00 | $1.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $212.5M | ||
| Q3 25 | $169.1M | $203.3M | ||
| Q2 25 | $154.7M | $147.5M | ||
| Q1 25 | $125.2M | $145.5M | ||
| Q4 24 | $149.7M | $144.7M | ||
| Q3 24 | $141.5M | $141.7M | ||
| Q2 24 | $126.7M | $137.9M | ||
| Q1 24 | $110.4M | $137.4M |
| Q4 25 | $1.7M | $75.3M | ||
| Q3 25 | $17.3M | $34.3M | ||
| Q2 25 | $-24.4M | $51.1M | ||
| Q1 25 | $-21.7M | $44.4M | ||
| Q4 24 | $14.7M | $50.0M | ||
| Q3 24 | $-6.7M | $42.9M | ||
| Q2 24 | $-15.7M | $51.3M | ||
| Q1 24 | $-48.4M | $47.8M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.3% | 21.8% | ||
| Q2 25 | -6.1% | 44.6% | ||
| Q1 25 | -6.3% | 39.3% | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 15.3% | 39.0% | ||
| Q2 24 | 11.8% | 48.1% | ||
| Q1 24 | -25.1% | 45.5% |
| Q4 25 | 0.9% | 35.5% | ||
| Q3 25 | 10.2% | 16.8% | ||
| Q2 25 | -15.8% | 34.6% | ||
| Q1 25 | -17.3% | 30.5% | ||
| Q4 24 | 9.8% | 34.6% | ||
| Q3 24 | -4.8% | 30.3% | ||
| Q2 24 | -12.4% | 37.2% | ||
| Q1 24 | -43.9% | 34.8% |
| Q4 25 | $0.00 | $1.51 | ||
| Q3 25 | $0.06 | $0.69 | ||
| Q2 25 | $-0.08 | $1.20 | ||
| Q1 25 | $-0.07 | $1.04 | ||
| Q4 24 | $0.05 | $1.18 | ||
| Q3 24 | $-0.02 | $1.01 | ||
| Q2 24 | $-0.05 | $1.21 | ||
| Q1 24 | $-0.16 | $1.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | — |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $3.6B |
| Total Assets | $949.9M | $24.9B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | — | ||
| Q3 25 | $263.8M | — | ||
| Q2 25 | $231.0M | — | ||
| Q1 25 | $250.6M | — | ||
| Q4 24 | $249.9M | — | ||
| Q3 24 | $249.8M | — | ||
| Q2 24 | $260.1M | — | ||
| Q1 24 | $239.6M | — |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $3.6B | ||
| Q3 25 | $230.4M | $3.5B | ||
| Q2 25 | $204.3M | $3.1B | ||
| Q1 25 | $193.6M | $3.0B | ||
| Q4 24 | $194.0M | $3.0B | ||
| Q3 24 | $178.8M | $3.0B | ||
| Q2 24 | $132.5M | $2.9B | ||
| Q1 24 | $130.7M | $2.9B |
| Q4 25 | $949.9M | $24.9B | ||
| Q3 25 | $868.8M | $25.0B | ||
| Q2 25 | $815.3M | $20.0B | ||
| Q1 25 | $789.8M | $19.9B | ||
| Q4 24 | $785.0M | $19.4B | ||
| Q3 24 | $786.6M | $19.4B | ||
| Q2 24 | $749.5M | $19.4B | ||
| Q1 24 | $721.8M | $19.3B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $78.9M |
| Free Cash FlowOCF − Capex | $16.0M | $75.5M |
| FCF MarginFCF / Revenue | 8.6% | 35.5% |
| Capex IntensityCapex / Revenue | 0.2% | 1.6% |
| Cash ConversionOCF / Net Profit | 9.62× | 1.05× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $239.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $78.9M | ||
| Q3 25 | $35.7M | $52.2M | ||
| Q2 25 | $-26.5M | $106.7M | ||
| Q1 25 | $7.8M | $13.3M | ||
| Q4 24 | $-3.9M | $42.9M | ||
| Q3 24 | $-23.0M | $70.2M | ||
| Q2 24 | $22.7M | $65.6M | ||
| Q1 24 | $-29.7M | $51.1M |
| Q4 25 | $16.0M | $75.5M | ||
| Q3 25 | $35.3M | $49.7M | ||
| Q2 25 | $-28.9M | $102.5M | ||
| Q1 25 | $7.5M | $11.3M | ||
| Q4 24 | $-4.2M | $36.5M | ||
| Q3 24 | $-23.3M | $64.4M | ||
| Q2 24 | $21.6M | $61.9M | ||
| Q1 24 | $-31.5M | $46.7M |
| Q4 25 | 8.6% | 35.5% | ||
| Q3 25 | 20.9% | 24.4% | ||
| Q2 25 | -18.7% | 69.5% | ||
| Q1 25 | 6.0% | 7.8% | ||
| Q4 24 | -2.8% | 25.2% | ||
| Q3 24 | -16.5% | 45.4% | ||
| Q2 24 | 17.0% | 44.9% | ||
| Q1 24 | -28.5% | 34.0% |
| Q4 25 | 0.2% | 1.6% | ||
| Q3 25 | 0.2% | 1.2% | ||
| Q2 25 | 1.6% | 2.9% | ||
| Q1 25 | 0.2% | 1.4% | ||
| Q4 24 | 0.2% | 4.4% | ||
| Q3 24 | 0.3% | 4.1% | ||
| Q2 24 | 0.9% | 2.7% | ||
| Q1 24 | 1.6% | 3.2% |
| Q4 25 | 9.62× | 1.05× | ||
| Q3 25 | 2.06× | 1.52× | ||
| Q2 25 | — | 2.09× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | -0.27× | 0.86× | ||
| Q3 24 | — | 1.64× | ||
| Q2 24 | — | 1.28× | ||
| Q1 24 | — | 1.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
INDB
Segment breakdown not available.
